It is a trading private limited company based in New Delhi, Delhi, India, established in 2012.
2012 | New Delhi, Delhi, India | ActiveWellborn Pharmaceuticals Private Limited, a active private limited company, was established on 19 September 2012 in New Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U51909DL2012PTC242504. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Shyam Kishor Sahay (Director), Rakesh Kumar Sinha (Director). It holds ₹0.80 M open charges and no settled loans. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 430 A, Sant Nagar East Of Kailash, New Delhi, Delhi, 110067.
U51909DL2012PTC242504
242504
19 September 2012
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Wellborn Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyam Kishor Sahay | Director | 19 Sep 2012 | Current |
| Rakesh Kumar Sinha | Director | 19 Sep 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Wellborn Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Wellborn Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2014 | Others | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Wellborn Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Wellborn Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellborn Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Wellborn Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was recorded as a recent event.
The activity Wellborn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was completed.
A charge with Others of Rs. 0.80 M registered on 06 Jun 2014 with Charge ID 10505340 was modified on 18 Oct 2017. was recorded as a recent event.
A charge with Others amounted to Rs. 0.80 M with Charge ID 10505340 was registered on 06 Jun 2014. was recorded as a recent event.
The activity Shyam Kishor Sahay was appointed as a Director was appointed as a Director on 19 Sep 2012 & has been associated with this company since 13 years 3 months . was completed.
Rakesh Kumar Sinha was appointed as a Director was appointed as a Director on 19 Sep 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
The CIN of Wellborn Pharmaceuticals Private Limited is U51909DL2012PTC242504.
Wellborn Pharmaceuticals Private Limited is headquartered at 430 A, Sant Nagar East Of Kailash, New Delhi, Delhi, 110067.
Wellborn Pharmaceuticals Private Limited was incorporated on 19 September 2012.
The current directors of Wellborn Pharmaceuticals Private Limited are
The primary industry of Wellborn Pharmaceuticals Private Limited is Trade.
Wellborn Pharmaceuticals Private Limited is unlisted.
The authorized capital of Wellborn Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Wellborn Pharmaceuticals Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX